|1.||Wu, T-C: 14 articles (01/2014 - 05/2003)|
|2.||Hung, Chien-Fu: 13 articles (01/2014 - 05/2003)|
|3.||McNeel, Douglas G: 11 articles (08/2015 - 12/2005)|
|4.||Esteller, Manel: 11 articles (03/2015 - 08/2003)|
|5.||Jenkins, Mark A: 8 articles (12/2015 - 04/2011)|
|6.||Lindor, Noralane M: 8 articles (12/2015 - 04/2005)|
|7.||Win, Aung Ko: 7 articles (12/2015 - 04/2011)|
|8.||Thibodeau, Stephen N: 7 articles (12/2015 - 04/2005)|
|9.||D'Andrea, Alan D: 7 articles (04/2015 - 04/2006)|
|10.||He, Liangmei: 7 articles (01/2013 - 05/2003)|
01/26/2005 - "These results indicate that a DNA vaccination may be effective against RSV infection even in very young infants and calves."
02/20/2006 - "Both groups of HA-vaccinated ponies were significantly protected from clinical disease following challenge infection, demonstrating the efficacy of rMVA vaccination with or without a DNA prime. "
02/01/2003 - "We have previously shown that mice immunized with a DNA vector expressing p36/LACK of Leishmania infantum followed by a booster with VVp36/LACK induced significant protection against Leishmania major infection. "
09/16/2011 - "These findings demonstrated that a DNA prime-protein boost immunization strategy, but not a DNA vaccine or protein vaccine alone, was effective in eliciting both humoral and cell-mediated immune responses against CVB3 infection in mice and might be a promising vaccine candidate."
07/01/1994 - "A DNA probe (Gen-Probe PACE 2) detects portions of viable and nonviable organisms, and test results could remain positive after effective treatment of genital Neisseria gonorrhoeae infection. "
01/01/2013 - "We then utilized this ST-expressing tumor cell line to test the efficacy of a DNA vaccine encoding ST. In ST-expressing tumor-bearing mice, this vaccine, pcDNA3-MCC/ST, generated a significant number of ST antigenic peptide-specific CD8+ T cells and experienced markedly enhanced survival compared to mice vaccinated with empty vector. "
10/21/2010 - "Therefore, priming with a DNA vaccine in the presence of α-GalCer and boosting with E7-pulsed DC-1 led to a significant enhancement of E7-specific CD8(+) effector and memory T-cells as well as significantly improved therapeutic and preventive effects against an E7-expressing tumor model (TC-1) in vaccinated mice. "
11/01/2006 - "We show the efficacy of a therapeutic strategy that combines the potency of a DNA-binding photosensitizer, UV(A)Sens, with the tumor-targeting potential of receptor-mediated endocytosis. "
05/15/2011 - "In particular, a novel cycle-amplifying technique using a DNA device on MBs was further employed in the ECL assay of cancer cells, which greatly improved the sensitivity. "
03/01/2013 - "In this report, we evaluated the immune and anti-tumor efficacy of a DNA vaccine targeting the AR LBD (pTVG-AR) in relevant rodent preclinical models. "
01/20/2013 - "In 2008, a DNA tumour virus, a polyomavirus (Merkel cell polyomavirus) was detected in Merkel cell carcinomas, and this finding helped to understand the etiological background of the disease. "
11/01/1998 - "Hence, this study shows that there is some relationship between intrinsic radiosensitivity and expression of a DNA repair enzyme in cervical carcinomas. "
11/01/1989 - "A morphometrical assessment of nuclear features and a DNA study were performed on prostate tissue specimens from 33 patients with prostate carcinoma using an image analysing computer. "
12/01/2013 - "The excision repair cross-complementation 1 (ERCC1) is a DNA repair gene coding 5' endonuclease in nucleotide excision repair and is overexpressed in chemo- or radioresistant carcinomas. "
06/01/2013 - "However, a DNA microarray experiment showed that many genes including Notch1 and Cdk1, which are known to be enhanced in ovarian carcinoma, are also increased in the ovaries of Selenbp1 (-/-) mice. "
01/01/2011 - "Immunogenicity and protective efficacy against murine tuberculosis of a prime-boost regimen with BCG and a DNA vaccine expressing ESAT-6 and Ag85A fusion protein."
02/01/2001 - "Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis."
06/01/2014 - "tuberculosis clinical isolates within 6 h using only simple instruments, such as a thermal cycler, a hybridization oven, and a DNA chip scanner, and less technician skill was required than for other techniques. "
03/01/2014 - "tuberculosis mutT gene, a homologue of a DNA repair protein in Escherichia coli. "
05/01/2013 - "tuberculosis and treated with a DNA vaccine in an immunotherapeutic regimen. "
08/01/2004 - "The immunogenicity and protective efficacy of a DNA and recombinant modified vaccinia Ankara (MVA) vaccine administered by two different routes were investigated. "
04/12/2007 - "Dose-response studies for the elicitation of CD8 T cells by a DNA vaccine, used alone or as the prime for a modified vaccinia Ankara boost."
01/01/2015 - "DCs targeted with a DNA vaccine encoding the immunodominant vaccinia B8R gene via RVG-P were able to restimulate vaccinia-specific memory T cells in vitro. "
01/01/2011 - "The immunogenicity of rLSDV-grttn was tested in homologous prime-boost regimens as well as heterologous prime-boost regimes in combination with a DNA vaccine (pVRC-grttn) or modified vaccinia Ankara vaccine (rMVA-grttn) both expressing Grttn. "
02/01/2009 - "Broad, high-magnitude and multifunctional CD4+ and CD8+ T-cell responses elicited by a DNA and modified vaccinia Ankara vaccine containing human immunodeficiency virus type 1 subtype C genes in baboons."
|1.||DNA (Deoxyribonucleic Acid)
|5.||Transcription Factors (Transcription Factor)
|8.||Azacitidine (5 Azacytidine)
|3.||Heterologous Transplantation (Xenotransplantation)